Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges

International Journal of Antimicrobial Agents
Marissa D MalchioneJesse L Goodman

Abstract

Carbapenem-resistant Enterobacteriaceae infections have spread globally, leaving polymyxins, including colistin, as 'last-resort treatments'. Emerging colistin resistance raises the spectre of untreatable infections. Despite this threat, data remain limited for much of the world, including Southeast Asia where only 3 of 11 nations submitted data on carbapenem and colistin resistance for recent World Health Organization (WHO) reports. To improve our understanding of the challenge, we utilised broad strategies to search for and analyse data on carbapenem and colistin resistance among Escherichia coli and Klebsiella in Southeast Asia. We found 258 studies containing 526 unique reports and document carbapenem-resistant E. coli and Klebsiella in 8 and 9 of 11 nations, respectively. We estimated carbapenem resistance proportions through meta-analysis of extracted data for nations with ≥100 representative isolates. Estimated resistance among Klebsiella was high (>5%) in four nations (Indonesia, Philippines, Thailand and Vietnam), moderate (1-5%) in two nations (Malaysia and Singapore) and low (<1%) in two nations (Cambodia and Brunei). For E. coli, resistance was generally lower but was high in two of seven nations with ≥100 isolates ...Continue Reading

References

Feb 26, 2000·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·H AriffinL H Peng
Feb 17, 2001·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·N ParasakthiA Arasu
Nov 3, 2001·International Journal of Antimicrobial Agents·G KumarasingheP A Tambyah
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Van CaoPatrice Courvalin
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Trung Vu NguyenAndrej Weintraub
Sep 17, 2005·Diagnostic Microbiology and Infectious Disease·Yoichi HirakataUNKNOWN SENTRY Asia-Pacific Participants
Jul 29, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Thi Anh Thu LeMichael Dibley
Feb 20, 2007·The Journal of Antimicrobial Chemotherapy·Anastasia AntoniadouHelen Giamarellou
Mar 6, 2007·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Selvi PalasubramaniamNavaratnam Parasakthi
Apr 27, 2007·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Nirmala Devi BaskaranI-Ching Sam
Jul 17, 2007·International Journal of Antimicrobial Agents·C P TengD C B Lye
Aug 25, 2007·International Journal of Antimicrobial Agents·Yoav Keynan, Ethan Rubinstein
Oct 24, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Selvi PalasubramaniamNavaratnam Parasakthi
Jan 8, 2008·International Journal of Antimicrobial Agents·Tse Hsien KohTse Yuen Koh
Feb 9, 2008·Emerging Infectious Diseases·Li-Yang HsuPaul Ananth Tambyah
Mar 25, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Pattarachai KiratisinThanit Nunthanasup
Jun 17, 2008·Critical Care : the Official Journal of the Critical Care Forum·James J Rahal
Jul 10, 2008·International Journal of Antimicrobial Agents·G KumarasingheC Chiu
Oct 25, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Anucha ApisarnthanarakLinda M Mundy
Dec 18, 2008·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Pannika R NiumsupSurang Dejsirilert
May 1, 2009·Emerging Infectious Diseases·Etienne RuppéGuillaume Arlet
May 14, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jennifer M LitzowDavid H Hamer
Aug 13, 2009·Journal of Biomedicine & Biotechnology·King-Ting LimKwai-Lin Thong
Jan 8, 2010·The Journal of Antimicrobial Chemotherapy·Guo-Bao TianYohei Doi
Mar 2, 2010·International Journal of Antimicrobial Agents·Thidarat NetikulPattarachai Kiratisin
Jan 29, 2011·Lancet·Richard J CokerPiya Hanvoravongchai
Mar 18, 2011·Tropical Medicine & International Health : TM & IH·M JohanssonH Hanberger
Aug 24, 2011·Antimicrobial Agents and Chemotherapy·Krisztina M Papp-WallaceRobert A Bonomo
Sep 17, 2011·American Journal of Respiratory and Critical Care Medicine·Doo Ryeon ChungUNKNOWN Asian Network for Surveillance of Resistant Pathogens Study Group
Oct 12, 2011·The Journal of Antimicrobial Chemotherapy·Nicole StoesserNicola Jones
Nov 26, 2011·Journal of Clinical Microbiology·Michelle N D BalmJeanette Teo
Dec 1, 2011·Scandinavian Journal of Infectious Diseases·Jaime Mei Fong ChienThuan Tong Tan
Jan 18, 2012·Tropical Medicine & International Health : TM & IH·Juliëtte A SeverinWil H Goessens

❮ Previous
Next ❯

Citations

Oct 6, 2019·The Journal of Antimicrobial Chemotherapy·Stamatis KarakonstantisAchilleas Gikas
Feb 28, 2020·Clinical Microbiology Reviews·Karen Bush, Patricia A Bradford
Dec 17, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Aunyarat KhanawapeeShigeyuki Hamada
Jan 19, 2021·F1000Research·Abdourahamane Yacouba, Ahmed Olowo-Okere
Apr 14, 2021·Journal of Infection and Public Health·Soumya GhoshMai M Zafer
Apr 25, 2021·Antimicrobial Resistance and Infection Control·Soo Tein NgoiCindy Shuan Ju Teh
Jun 26, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Kathleen Tompkins, David van Duin
Aug 8, 2021·The Science of the Total Environment·Shaqiu ZhangAnchun Cheng
Jun 29, 2021·Antimicrobial Agents and Chemotherapy·Thitiya YungyuenUNKNOWN Research University Network Thailand Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.